EMEA-000237-PIP01-08-M10
Key facts
Invented name |
Edarbi
|
Active substance |
Azilsartan medoxomil
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0530/2021
|
PIP number |
EMEA-000237-PIP01-08-M10
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of hypertension
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Takeda Development Centre Europe Ltd
Email: Pediatrics@tgrd.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|